Exagen Management

How experienced are the management team and are they aligned to shareholders interests?

1.7yrs

Average management tenure


CEO

John Aballi (37 yo)

0.083yr

Tenure

Mr. John Aballi serves as President, Chief Executive Officer and Director at Exagen Inc. since October 17, 2022. Most recently he served as SVP, General Manager, Urology & CLIA COO at Veracyte Inc. Mr. Aba...


Leadership Team

NamePositionTenureCompensationOwnership
Kamal Adawi
CFO & Corporate Secretary5.42yrsUS$1.41m0.038%
$ 20.9k
Debra Zack
Chief Medical Officer2.67yrsUS$1.43m0.038%
$ 20.9k
John Aballi
CEO, President & Director0.083yrno datano data
Mark Hazeltine
Chief Operating Officer1.67yrsno data0.11%
$ 59.4k
Ming-Chou Lee
Chief Technology Officer1.25yrsno datano data
Ryan Douglas
Investors Relations Officerno datano datano data
John Wegener
Senior Vice President of Sales and Marketing9yrsno datano data
Andrew Concoff
Chief Innovation Officer & Member of Rheumatoid Arthritis Scientific Advisory Board0.083yrno datano data

1.7yrs

Average Tenure

48yo

Average Age

Experienced Management: XGN's management team is not considered experienced ( 1.7 years average tenure), which suggests a new team.


Board Members

NamePositionTenureCompensationOwnership
John Aballi
CEO, President & Director0.083yrno datano data
Andrew Concoff
Chief Innovation Officer & Member of Rheumatoid Arthritis Scientific Advisory Board2.92yrsno datano data
Kenneth Bloom
Member of Breast Cancer Advisory Boardno datano datano data
Mark Pegram
Member of Breast Cancer Advisory Boardno datano datano data
Bruce Robertson
Independent Director3.33yrsUS$142.26k0%
$ 0
Thomas Williams
Member of Breast Cancer Advisory Boardno datano datano data
Sanjeev Arora
Chairperson of Hepatitis C Advisory Boardno datano datano data
Brian Birk
Independent Chairman of the Board14.33yrsUS$153.76k0%
$ 0
G. Budd
Chairman of Breast Cancer Advisory Boardno datano datano data
Michael Press
Member of Breast Cancer Advisory Boardno datano datano data
Arthur Weinstein
Chairman of Scientific Advisory Board2.92yrsUS$130.00kno data
Frank Stokes
Additional Independent Director1.42yrsUS$160.60k0%
$ 0

2.9yrs

Average Tenure

61yo

Average Age

Experienced Board: XGN's board of directors are not considered experienced ( 2.9 years average tenure), which suggests a new board.